David Johnson
Chairman
ENvue Medical, Inc. (FEED)Board Member
Arthur J. Gallagher & Co. (AJG)Board Member
Caribou Biosciences, Inc. (CRBU)Board Member
ENvue Medical, Inc. (FEED)Board Member
Aura Biosciences, Inc. (AURA)Board Member
Enveric Biosciences, Inc. (ENVB)Board Member
Zentalis Pharmaceuticals, Inc. (ZNTL)Equibles does not estimate personal net worth.
Get an email with a short summary when ENvue Medical, Inc. publishes a filing, an earnings call transcript or a press release.
Get FEED alertsAbout David Johnson
David Johnson is recorded as Board Member at ENvue Medical, Inc. (FEED) since December 4, 2025, Chairman at ENvue Medical, Inc. (FEED), Board Member at Arthur J. Gallagher & Co. (AJG), CFO at Rank One Computing Corp (ROC), Board Member at Caribou Biosciences, Inc. (CRBU), COO at Vera Therapeutics, Inc. (VERA), Board Member at Aura Biosciences, Inc. (AURA) since January 1, 2021, CEO and Board Member at Enveric Biosciences, Inc. (ENVB) since December 30, 2020 and Board Member at Zentalis Pharmaceuticals, Inc. (ZNTL) since January 1, 2020. The newest filing on record that lists David Johnson as Chairman at ENvue Medical, Inc. (FEED) is dated November 10, 2025. The newest filing on record that lists David Johnson as Board Member at Arthur J. Gallagher & Co. (AJG) is dated March 23, 2026. ENvue Medical, Inc. reported in an 8-K filed July 14, 2026 that David Johnson resigned as member of the Board of Directors, effective July 14, 2026. ENvue Medical, Inc. reported in an 8-K filed February 6, 2026 that David Johnson was appointed Chairman of the Company's Board of Directors, effective February 2, 2026. ENvue Medical, Inc. reported in an 8-K filed December 5, 2025 that David Johnson was appointed director, effective December 4, 2025. Equibles holds 4 filed executive changes naming David Johnson; each is listed under recent activity with its source filing. The proxy statement of Vera Therapeutics, Inc. reports total compensation of $2,721,412 for David Johnson in fiscal 2025, including a base salary of $510,000. Disclosed compensation is on record for 3 fiscal years. David Johnson has spoken on 1 earnings call across 1 company, most recently for Rank One Computing Corp on September 30, 2025. Arthur J. Gallagher & Co. is classified in the Insurance Brokers industry within the Financial Services sector. Aura Biosciences, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Rank One Computing Corp includes Dr. Anil Jain (Board Member) and Dr. Kathleen L. Kiernan (Board Member).
“On July 14, 2026, each of David Johnson and Nino Pionati voluntarily resigned from their respective positions as members of the Board of Directors (the "Board") of ENvue Medical, Inc. (the "Company").”
“On February 2, 2026, the Company entered into a chairman agreement with David Johnson (the "Chairman Agreement"), pursuant to which Mr. Johnson shall serve as the Chairman of the Company's Board of Directors (the "Board").”
David Johnson on recent calls
“In yesterday's earnings release, we provided detailed third quarter and 9-month financial tables. So I'll use this time to offer further insight into specific financial metrics.”
Affiliation history
-
Current
2025-12-04–present
-
Current
2021-01-01–present
Last confirmed April 20, 2026
-
Current
2020-12-30–present
-
Current
2020-12-30–present
-
Current
2020-01-01–present
Last confirmed April 30, 2026
-
Current
Start not stated–present
Last confirmed November 10, 2025
-
Current
Start not stated–present
Last confirmed March 23, 2026
-
Current
-
Current
Start not stated–present
Last confirmed April 24, 2026
-
Current
Start not stated–present
Last confirmed April 9, 2026
-
Pfizer Inc (PFE)
Source not stated
Current -
2025-12-04–2026-07-14
-
Start not stated–2022-09-23
Last confirmed by a filing; no departure on record
Company network
Biotechnology · Healthcare
CEO, Board Member
2020-12-30–present
FEED
Medical Devices · Healthcare
Chairman, Board Member
2025-12-04–present
Biotechnology · Healthcare
Board Member
2020-01-01–present
Leadership on record at Rank One Computing Corp
- Dr. Anil Jain Board Member
- Dr. Kathleen L. Kiernan Board Member
Leadership on record at Arthur J. Gallagher & Co.
- Pat Gallagher CEO
- Patrick M. Gallagher COO
- Walt Bay General Counsel
- Kyle G. Koreyva Chief Accounting Officer
- Chris Miskel Board Member
- Christopher C. Miskel Board Member
- Deborah Caplan Board Member
- John Coldman Board Member
- Norman Rosenthal Board Member
- Ralph Nicoletti Board Member
Leadership on record at Aura Biosciences, Inc.
- Elisabet de los Pinos CEO, Board Member
- Natalie Holles CEO, Board Member
- Amy Elazzouzi CFO, Chief Accounting Officer
- Anthony Gibney CFO
- Julie B. Feder CFO
- Mark De Rosch COO
- Susan Abu-Absi COO
- Mark Plavsic CTO
- Conor Kilroy General Counsel
- Jeremy Bender, Ph.D., M.B.A. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Vera Therapeutics, Inc. (VERA) | Chief Operating Officer | $510,000 | $2,721,412 |
| 2024 | Vera Therapeutics, Inc. (VERA) | Chief Operating Officer | — | — |
| 2023 | Vera Therapeutics, Inc. (VERA) | Chief Operating Officer | — | — |